An antibody (anti-p2lser) was raised against a ras p21-related synthetic peptide and was able to recognize specifically the substitution of serine for glycine at amino acid 12 of p21. This substitution causes oncogenic activation of p21. Anti-p2lser was found to immunoprecipitate v-Ki-ras p21 and to strongly inhibit its ability to autophosphorylate and to bind GTP in an immunoabsorption assay. Furthermore, binding of the antibody to p21 was specifically inhibited by GTP or GDP, suggesting that amino acids around position 12 are part of the GTP/GDP binding site. These results, taken together with the observation that the microinjection of anti-p2lser into cells transformed by v-Ki-ras p21 causes a transient reversion of the cells to a normal phenotype [Feramisco, J. R., Clark, R., Wong, G., Arnheim, N., Milley, R. & McCormick, F. (1985) Nature (London) 314; 639-642], support the idea that interaction of p21 with guanine nucleotides is crucial to the transforming function of this protein.
The p21 proteins, encoded by members of the ras protooncogene family, cause the neoplastic transformation of certain cells in culture when activated through somatic mutation and have been implicated in the generation of a variety of human cancers. The most frequently observed mutation leading to the oncogenic activation of p21 results in the alteration of the glycine residue at position 12 of the protein to any of several other residues (1). p21 is known to specifically bind to GTP and hydrolyze it to GDP and inorganic phosphate (2) (3) (4) (5) . Substitution of valine for glycine at position 12 reduces the rate of GTP hydrolysis by a factor of about 10 (3-5) . In forms of p21 that contain a threonine residue at position 59, phosphate is transferred to this residue by an autophosphorylation reaction (2, 6 ). The precise role of these activities in the transforming potential of activated p21 is not known. To learn more about the mechanism of p21 activation, we have used synthetic peptides (7) (8) (9) to produce an antibody (anti-p2lser) that specifically recognizes the substitution of serine for glycine at position 12 in an activated p21 (v-Ki-ras) and have used this antibody as a specific probe to study the structure and biochemical functions of p21.
MATERIALS AND METHODS
Synthetic Peptides. The peptide shown in Fig. 1 was synthesized with an automated SAM Peptide Synthesizer (Biosearch, San Rafael, CA) using standard solid-phase chemistry (11) . Homogeneity of the peptide was confirmed by reversed-phase HPLC and amino acid analysis. Conjugation of the peptide to the carrier was achieved by a crosslinking reagent, a 6-(N-maleimido)aminocaproic acid ester of the sodium salt of 4-hydroxy-3-nitro-benzenesulfonic acid. This reagent couples via its active ester to amino groups of carrier proteins; the coupling can be quantitated by monitoring the release of 4-hydroxy-3-nitrobenzenesulfonate. Coupling of peptide to carrier results from the reaction of the maleimido group with the sulfhydryl group of the cysteine on the peptide. A complete description of this procedure will be published elsewhere.
Immunization. New Zealand White rabbits were immunized with 0.5 mg of the keyhole limpet hemacyanin derivatives of the peptides by peripheral lymph node injection in Freund's complete adjuvant followed 2 weeks later by a 0.5-mg subcutaneous injection in Freund's incomplete adjuvant. Three additional 0.5-mg subcutaneous booster injections were given at 3-week intervals. One month later, three intravenous injections (0.5 mg each) were given 4 days apart, and the serum used in these studies was taken 11 days later. Antisera were screened by procedures to be published elsewhere.
Affinity Purification. Anti-p2lser was affinity-purified by passage of serum over a column to which a peptide-bovine serum albumin conjugate similar to that shown in Fig. 1 was attached; this peptide contained glycine instead of serine at position 12. The flow-through from this column was passed over a second column to which the peptide shown in Fig. 1 The amino acid sequence of the first 20 residues common to the normal N-, Ki-, and Ha-ras p21 family members is shown in capital letters (10) . The sequence of the peptide immunogen is shown below in lower-case letters. The substitution at position 12, which is characteristic of the v-Ki-ras oncogene, is shown in boldface. The peptide was coupled to carrier protein (bovine serum albumin or keyhole limpet hemocyonin) at a cysteine residue between the amino acids corresponding to positions 16 and 17 of p21. Mal-Sac, 6-(N-maleimido)aminocaproyl.
RESULTS
Antibodies directed against an epitope of v-Ki-ras p21 that includes amino acid residue 12 (serine) were generated in Ha(Arg) rabbits by immunization with a p21-related peptide (Fig. 1) . The antiserum thus obtained (anti-p2lser) was found to bind to v-Ki-ras p21 synthesized in E. coli carrying pIN III-ras (a gift from M. Inouye), as shown by immunoprecipitation of (25 ,ul) of E. coli extracts (32P labeled) containing v-Ki-ras p21 were incubated with 0.2 ,ug of monoclonal antibody (mAb) Y13-259 (a gift from M. Furth, Sloan-Kettering) (lane 1) or with 10 ,ul of anti-p2lser (lane 3) or anti-p2lgly (serum raised against a peptide identical to that shown in Fig. 1 , except that glycine was substituted for serine) (lane 2). NaDodSO4 (0.5%) and dithiothreitol (2 mM) were added to reactions containing anti-p2lser and anti-p21 gly. Immunocomplexes were collected on 10 ,l of protein A-Sepharose beads precoated with affinity-purified goat anti-rat IgG in reactions utilizing mAb Y13-259 and rat IgG. Immunocomplexes were washed with 0.5% Nonidet P-40/50 mM Tris Cl, pH 8.0/1 M LiCl/120 mM NaCl and analyzed by NaDodSO4/PAGE and autoradiography. (B) Extracts of 32P-labeled KP6-cells (containing v-Ha-ras p21; arginine at position 12) or K-Balb cells (containing v-Ki-ras p21; serine at position 12) were reacted with 0.25 ,ug of mAb Y13-259 (lanes 1), 0.25 ,g of rat IgG (lanes 2), 5 jig of affmiity-purified anti-p2lser antiserum (lanes 3), or 5 ,g of preimmune rabbit serum (lanes 4) in the presence of 0.1% NaDodSO4 and 2 mM dithiothreitol for 1 hr at room temperature. Immunocomplexes were collected and analyzed as in A. (C-E) p21 was immunoprecipitated from Hs242 (lanes G) or K-Balb (lanes S) cell extracts with mAb Y13-259 as described for A, resolved by NaDodSO4/PAGE, and electrophoretically transferred to CNBr-activated filter paper (13, 14) . After transfer, the paper was probed with -25I-labeled mAb Y13-259 (0.1 Ag/ml, 5 uCi) (C), anti-p2lser (2 ,ul/ml) (D), or preimmune rabbit serum (2 14/ml) (E). Filters in D and Ewere treated with 125I-labeled protein A (5,ug/ml, 0.1,Ci) to label filter-bound antibody.
The filters were washed and autoradiographed.
Biochemistry: Clark et al.
Proc. Natl. Acad. Sci. USA 82 (1985) 32P-labeled p21 from an E. coli lysate (Fig. 2 A efficient immunoprecipitation with whole serum required, however, the use of detergent (0.05% NaDodSO4, 0.5% deoxycholate, or 0.5% octylglucoside) and reducing agent (2 mM dithiothreitol). The amino acid sequence surrounding position 12 is largely hydrophobic; we reasoned, therefore, that these conditions might facilitate exposure of this epitope to the antibody.
The specificity of anti-p2lser for the serine at position 12 was tested by immunoprecipitation of p21 from 32P-labeled extracts of cells transformed by either v-Ki-ras (serine at position 12) or v-Ha-ras (arginine at position 12) (Fig. 2B) . The affinity-purified rabbit antibody efficiently precipitated the p21 containing serine but not arginine at position 12 (16) . Extracts were immunoprecipitated with mAb Y13-259, and immunocomplexes were electrophoresed in NaDodSO4/polyacrylamide gels. Proteins were transferred to filters and probed with anti-p2lser or Y13-259 (as a control). Anti-p2lser did not react with Hs242 p21 in this assay, although it did react efficiently with v-Ki-ras p21, as expected ( Fig. 2C-E) . Anti-p2lser also fails to immunoprecipitate p21 produced in E. coli carrying pIN III-ras that has been altered by site-directed mutagenesis (M. Innis and P. McCabe, Cetus Corporation) to code for either glycine or valine at position 12 (details to be published elsewhere). These results, and those described above, indicate that the serine-12 is included in the anti-p2lser epitope. In contrast, mAbs made against a similar peptide in which valine substitutes for glycine at position 12 reacts with both normal and mutant protein (17) .
Since comparative sequence analyses suggested that the portion of p21 surrounding position 12 might be involved in the interaction of p21 with GTP (18, 19) , we sought to determine how the binding of our antibody to position 12 might affect p21-GTP interaction. As shown in Fig. 3 , the GTP-dependent autophosphorylation ofE. coli-produced p21 v-Ki-ras is completely eliminated after immunoprecipitation by anti-p2lser. In contrast, this p21 is efficiently autophosphorylated after immunoprecipitation with mAb Y13-259. This mAb fails to inhibit GTP hydrolysis p21 (4), although it may reduce, directly or indirectly, the binding of GTP to p21 (15) . When the p21 is phosphorylated prior to immunoprecipitation, approximately equal amounts of 32P-labeled p21 are precipitated with each antibody.
To confirm the above result and determine whether the antibody blocked the binding of GTP rather than the transfer of phosphate to threonine-59, we tested the ability of antip2lser to directly block the binding of [a-32P]GTP to p21 in a mAb-linked immunoabsorption assay (Fig. 4) . After treatment with anti-p2lser, GTP binding to immunoprecipitated p21 was reduced by a factor of 5, whereas no reduction was seen with control antibody.
Having established that binding of anti-p2lser to p21
inhibits GTP binding, we asked whether the reciprocal effect could be demonstrated. Fig. 5 shows that prior incubation with either GTP or GDP but not ATP inhibited binding of anti-p21ser to p21. The concentration of guanine nucleotide required for inhibition was -0.01 mM. Incubation of p21 with up to 10 mM GTP, GDP, or ATP had no effect on binding of mAb Y13-259 to p21 (data not shown). DISCUSSION In this paper, we describe the use of peptide immunogens to produce antibodies that recognize an epitope of p21 including amino acid 12. These antibodies react with the protein in cell extracts in the presence of detergent (0.05% NaDodSO4, 0.5% deoxycholate, or 0.5% n-octylglucoside) and 2 mM dithiothreitol. The amino acids around position 12 are largely hydrophobic and do not appear to be freely accessible without these additions. In contrast to anti-p21 antibodies described previously (15) , anti-21ser specifically blocks binding of GTP to p21 and, conversely, guanine nucleotides prevent interaction of the antibody with p21.
The simplest explanation for these results is that the anti-p2lser binding site (18, 19) . In addition, the discovery that substitution of valine for glycine at position 12 reduces intrinsic GTPase activity of p21 provides further evidence that sequences at or around position 12 interact with GTP (3) (4) (5) . Recent data on the structure of other guanine nucleotide binding proteins provide further insight into the structure-function relationship in p21. For example, the bacterial elongation factor EF-Tu binds GTP and GDP with high specificity and has primary sequence homology with p21 and other guanine nucleotide binding proteins (20, 22, 23) . The EF-Tu GDP binding site is composed of four polypeptide loops, each of which span a transition from a a-strand to an a-helical secondary structure (21, 24) . It is likely that the p21 GTP (21) .
The high specificity of anti-p2lser for p21 that has been activated through the substitution of serine for glycine at position 12, taken together with its ability to modulate p21 FIG. 5 . Inhibition of anti-p2lser binding to p21 by GTP and GDP. Five microliters of an extract from E. coli expressing v-Ki-ras p21 was 32P-labeled as described in the legend to Fig. 3B . GTP, GDP, or ATP was added as indicated to 0.1 mM and incubated for 30 min at 220C. The extract was diluted 10-fold with buffer containing 5 mM EDTA, 0.5% n-octylglucoside, 150 mM NaCl, 20 mM Tris Cl (pH 7.5), 2 mM dithiothreitol, and 5 gl of anti-p2lser serum or 0. biochemical activity, makes this antibody a very useful probe for studying the structure of p21 and its role in oncogenesis both in vitro and in vivo. An example of its effectiveness in vivo has been reported (25) . Briefly, microinjection of antip2lser into cells transformed by v-Ki-ras causes their transient reversion to a normal phenotype. This result provides evidence that GTP binding is essential to the transforming function of ras p21. Potentially, this antibody could be used to control p21 activity in complex in vitro systems and to probe its interactions with other cellular components. Furthermore, our demonstration of the feasibility of producing antibodies capable of detecting the activation of p21 by glycine-to-serine substitution and by other substitutions (unpublished data) raises the possibility that these sera may be useful diagnostic reagents for human cancer.
